Levijoki J - Search Results

1

The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig.

Szilágyi S, Pollesello P, Levijoki J, Kaheinen P, Haikala H, Edes I, Papp Z. Szilágyi S, et al. Among authors: levijoki j. Eur J Pharmacol. 2004 Feb 13;486(1):67-74. doi: 10.1016/j.ejphar.2003.12.005. Eur J Pharmacol. 2004. PMID: 14751410

2

Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting.

Levijoki J, Saloranta L, Tuunainen J, Kaskinoro J, Pappinen S, Nourry S, Betat AM, Maurin A, Pakarinen M, Häkkinen S, Tervapuro J, Pihlasvaara H, Drieu La Rochelle C, Joensuu H. Levijoki J, et al. J Pharmacol Exp Ther. 2023 Mar;384(3):439-444. doi: 10.1124/jpet.122.001444. Epub 2023 Jan 12. J Pharmacol Exp Ther. 2023. PMID: 36635086

3

Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.

Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Lindén IB. Haikala H, et al. Among authors: levijoki j. J Cardiovasc Pharmacol. 1995 May;25(5):794-801. doi: 10.1097/00005344-199505000-00016. J Cardiovasc Pharmacol. 1995. PMID: 7630157

4

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan.

Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Lindén IB. Haikala H, et al. Among authors: levijoki j. J Mol Cell Cardiol. 1995 Sep;27(9):1859-66. doi: 10.1016/0022-2828(95)90009-8. J Mol Cell Cardiol. 1995. PMID: 8523447

5

Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension.

Haikala H, Levijoki J, Lindén IB. Haikala H, et al. Among authors: levijoki j. J Mol Cell Cardiol. 1995 Oct;27(10):2155-65. doi: 10.1016/s0022-2828(95)91371-8. J Mol Cell Cardiol. 1995. PMID: 8576932

6

The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.

Haikala H, Kaheinen P, Levijoki J, Lindén IB. Haikala H, et al. Among authors: levijoki j. Cardiovasc Res. 1997 Jun;34(3):536-46. doi: 10.1016/s0008-6363(97)00057-6. Cardiovasc Res. 1997. PMID: 9231037

7

Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan.

Levijoki J, Pollesello P, Kaivola J, Tilgmann C, Sorsa T, Annila A, Kilpeläinen I, Haikala H. Levijoki J, et al. J Mol Cell Cardiol. 2000 Mar;32(3):479-91. doi: 10.1006/jmcc.1999.1093. J Mol Cell Cardiol. 2000. PMID: 10731446

8

Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels.

Kaheinen P, Pollesello P, Levijoki J, Haikala H. Kaheinen P, et al. Among authors: levijoki j. J Cardiovasc Pharmacol. 2001 Apr;37(4):367-74. doi: 10.1097/00005344-200104000-00003. J Cardiovasc Pharmacol. 2001. PMID: 11300649

9

Improved survival with simendan after experimental myocardial infarction in rats.

Levijoki J, Pollesello P, Kaheinen P, Haikala H. Levijoki J, et al. Eur J Pharmacol. 2001 May 11;419(2-3):243-8. doi: 10.1016/s0014-2999(01)00997-9. Eur J Pharmacol. 2001. PMID: 11426847

10

Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.

Kaheinen P, Pollesello P, Levijoki J, Haikala H. Kaheinen P, et al. Among authors: levijoki j. J Cardiovasc Pharmacol. 2004 Apr;43(4):555-61. doi: 10.1097/00005344-200404000-00011. J Cardiovasc Pharmacol. 2004. PMID: 15085067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters